IMPA1 抗体 (AA 227-277)
Quick Overview for IMPA1 抗体 (AA 227-277) (ABIN7450359)
抗原
See all IMPA1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 227-277
-
原理
- Rabbit anti-IMPA1 Antibody, Affinity Purified
-
预测反应
- Bovine,Pig,Orangutan
-
纯化方法
- Affinity Purified
-
免疫原
- Between AA 227 and 277
-
亚型
- IgG
-
-
-
-
应用备注
-
IP: 2 - 10 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
限制
- 仅限研究用
-
-
-
浓度
- 1000 μg/mL
-
缓冲液
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
有效期
- 12 months
-
-
- IMPA1 (Inositol(myo)-1(or 4)-Monophosphatase 1 (IMPA1))
-
别名
- IMPA1
-
背景
- Background: Inositol monophosphatase 1 (IMPA1) is an enzyme that dephosphorylates myo-inositol monophosphate to generate free myo-inositol, a precursor of phosphatidylinositol, and is therefore an important modulator of intracellular signal transduction via the production of the second messengers myoinositol 1,4,5-trisphosphate and diacylglycerol. This enzyme can also use myo-inositol-1,3-diphosphate, myo-inositol-1,4-diphosphate, scyllo-inositol-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates. IMPA1 shows magnesium-dependent phosphatase activity and is inhibited by therapeutic concentrations of lithium. Inhibition of inositol monophosphate hydroylosis and subsequent depletion of inositol for phosphatidylinositol synthesis may explain the anti-manic and anti-depressive effects of lithium administered to treat bipolar disorde [taken from NCBI Entrez Gene (Gene ID: 3612)].
-
基因ID
- 3612
-
UniProt
- P29218
抗原
-